PRE (PRE) revenue breakdown
By segment, Consumer Health is the largest at 86% of fiscal 2025 revenue, growing 1327% a year over 1 years.
By product, Consumer health - health and wellness solutions is the largest at 65% of fiscal 2025 revenue, growing 16156% a year over 1 years.
Revenue by segment
Fiscal years, as PRE reports them in its 10-K filings; fiscal 2025 total $92M.
| Segments | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|
| Consumer Health | — | — | — | — | $6M | $79M | 86% |
| Prevention | $14M | $17M | $16M | $6M | $10M | $13M | 14% |
| Diagnostics | $51M | $259M | $260M | $16M | — | — | — |
Revenue by product
Fiscal years, as PRE reports them in its 10-K filings; fiscal 2025 total $92M.
| Products | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|
| Consumer health - health and wellness solutions | — | $370,000 | $60M | 65% |
| Consumer health - sports distribution | — | $5M | $19M | 21% |
| Prevention - genetic testing | $6M | $10M | $13M | 14% |
| Diagnostics - Cancer Treatment | $16M | — | — | — |
Revenue by region
Fiscal years, as PRE reports them in its 10-K filings; fiscal 2025 total $92M.
| Regions | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|
| The United States | — | — | — | — | $6M | $69M | 75% |
| Hong Kong | $35M | $125M | $211M | $9M | $10M | $23M | 25% |
| Taiwan | — | — | — | $9M | — | — | — |
| United Kingdom | $30M | $151M | $65M | $2M | — | — | — |
| Rest of the world | — | — | — | $1M | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PRE.
Open PRE in InvestinglyQuestions
Where does PRE make its money?
In fiscal 2025, by segment: Consumer Health $79M, Prevention $13M.
From PRE's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.